Pacira BioSciences (PCRX) Earnings Date
The next earnings date for Pacira BioSciences (PCRX) is expected by Feb 16, 2027, per the data provider's calendar.
- Next earnings date
- Feb 16, 2027
- expected by · quarter ending Dec '26
- Consensus EPS
- $0.85
- Dec '26 quarter · 3 analysts
- Consensus revenue
- $200.6M
- Dec '26 quarter · 2 analysts
- Latest stored quarter
- EPS 0.70
- revenue $176.7M · reported Nov 5, 2026
Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
0 of 1 scored quarter beat.
| Report | Est EPS | Act EPS | Surprise | Est rev | Act rev | Rev surp. | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026press release, before open · 6:59 am ET | 0.73 | 0.70 | −4.3% | $182.9M | $176.7M | −3.4% | +0.1%release day |
| Aug 4, 2026 filed | 0.65adjusted basis | 0.12 | —a Withheld: the reported earnings per share fall well short of the estimate while revenue does not, the usual sign of an adjusted estimate set against reported earnings. | $191.1M | $192.4M | +0.7% | —filing date only |
| Apr 30, 20268-K, after close · 4:03 pm ET | — | 0.07 | — | — | $177.4M | — | −4.1%next session |
| Feb 26, 20268-K, after close · 4:02 pm ET | — | 0.05 | — | — | $196.9M | — | −3.0%next session |
| Nov 6, 20258-K, after close · 4:04 pm ET | — | 0.12 | — | — | $179.5M | — | +4.5%next session |
| Aug 5, 20258-K, after close · 4:01 pm ET | — | −0.11 | — | — | $181.1M | — | −0.6%next session |
| May 8, 20258-K, after close · 4:06 pm ET | — | 0.10 | — | — | $168.9M | — | +0.8%next session |
| Jan 10, 20258-K, before open · 8:01 am ET | — | 0.38 | — | — | $187.3M | — | +11.1%release day |
- a Withheld: the reported earnings per share fall well short of the estimate while revenue does not, the usual sign of an adjusted estimate set against reported earnings.
1 of the 8 quarters above is scored against the consensus we stored the night before each report; we began storing it in Jul 2026. 6 reported before we stored a consensus for them, so they are not scored. 1 is not scored for the reason marked beside it. We never backfill an estimate we didn't observe.
filed marks a quarter where we found no results release and hold only the date its report was filed. A filing can trail the release by days or weeks, so those rows show no reaction rather than the move of an unrelated session.
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 3 | 3 | 4 | 5 |
| Avg estimate | 0.85 | 0.77 | 2.93 | 3.59 |
| Low estimate | 0.75 | 0.72 | 2.88 | 3.29 |
| High estimate | 0.98 | 0.81 | 3.02 | 3.81 |
| Year-ago EPS | 0.05 | 0.07 | 0.16 | 2.93E |
| Implied growth | +1592.2% | +1000.0% | +1734.0% | +22.3% |
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 2 | 2 | 2 | 6 |
| Avg estimate | $200.6M | $180.4M | $751.3M | $787.8M |
| Low estimate | $199.5M | $179.7M | $748.3M | $782.1M |
| High estimate | $202.2M | $181.0M | $754.2M | $793.7M |
| Year-ago revenue | $196.9M | $177.4M | $726.4M | $751.3ME |
| Implied growth | +1.9% | +1.7% | +3.4% | +4.9% |
| Snapshot age | Dec '26, period ending Dec 30, 2026 | Mar '27, period ending Mar 30, 2027 | FY26, period ending Dec 31, 2026 | FY27, period ending Dec 31, 2027 |
|---|---|---|---|---|
| Current estimate | 0.83 | 0.73 | 2.90 | 3.51 |
| 7 days ago | 0.83 | — | 2.89 | 3.44 |
| 30 days ago | 0.83 | — | 2.90 | 3.46 |
| 60 days ago | 0.83 | — | 2.89 | 3.44 |
| 90 days ago | 0.84 | — | 2.88 | 3.45 |
Estimate history accrues from our nightly snapshots. The 7/30/60/90-day rows fill in as tracking continues. Each column follows one fiscal period back through our snapshots; a dash means we had not recorded that period at that age. A rising bar makes a beat streak more meaningful; a falling one manufactures beats.
Dec '26 quarter consensus moved $0.84 → $0.85 over 90 tracked days, the same quarter at both ends. Per-analyst up/down revision counts aren't in our data feed. We show the bar's actual movement instead of guessing.
Common questions
When does Pacira BioSciences report earnings next?
Pacira BioSciences' next earnings date is expected by Feb 16, 2027, per the data provider's calendar.
What were Pacira BioSciences' latest quarterly earnings?
Pacira BioSciences reported diluted EPS of 0.70 and revenue of $176.7M on Nov 5, 2026.
How did Pacira BioSciences' stock move after its last earnings report?
Pacira BioSciences moved +0.1% in the session after its Nov 5, 2026 report.

